Wolfe Research Initiates Coverage on Mettler-Toledo International (NYSE:MTD)

Analysts at Wolfe Research assumed coverage on shares of Mettler-Toledo International (NYSE:MTD) in a research report issued to clients and investors on Friday. The brokerage set a “peer perform” rating on the medical instruments supplier’s stock.

MTD has been the subject of a number of other research reports. Evercore ISI boosted their price objective on Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the company an “in-line” rating in a report on Tuesday, October 1st. Robert W. Baird decreased their price objective on shares of Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating on the stock in a report on Monday, November 11th. Citigroup upgraded shares of Mettler-Toledo International from a “sell” rating to a “neutral” rating and increased their price objective for the company from $1,200.00 to $1,300.00 in a report on Wednesday. Wells Fargo & Company cut their price objective on Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating for the company in a research report on Monday, November 11th. Finally, Stifel Nicolaus lowered their price objective on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a research note on Monday, November 11th. One analyst has rated the stock with a sell rating, seven have given a hold rating and two have assigned a buy rating to the company. According to MarketBeat, Mettler-Toledo International presently has an average rating of “Hold” and an average target price of $1,351.25.

Mettler-Toledo International Stock Performance

Shares of NYSE MTD traded down $11.42 during midday trading on Friday, hitting $1,265.50. 47,618 shares of the company traded hands, compared to its average volume of 135,201. The stock has a 50-day moving average price of $1,309.36 and a 200 day moving average price of $1,378.81. The firm has a market cap of $26.70 billion, a P/E ratio of 34.02, a P/E/G ratio of 4.19 and a beta of 1.13. Mettler-Toledo International has a 12-month low of $1,115.64 and a 12-month high of $1,546.93.

Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $10.00 by $0.21. Mettler-Toledo International had a negative return on equity of 531.78% and a net margin of 21.15%. The firm had revenue of $954.54 million for the quarter, compared to the consensus estimate of $941.93 million. As a group, equities analysts expect that Mettler-Toledo International will post 40.42 earnings per share for the current year.

Insider Buying and Selling at Mettler-Toledo International

In other news, insider Gerry Keller sold 140 shares of Mettler-Toledo International stock in a transaction dated Tuesday, December 3rd. The shares were sold at an average price of $1,254.09, for a total value of $175,572.60. Following the sale, the insider now owns 6 shares of the company’s stock, valued at $7,524.54. The trade was a 95.89 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Elisha W. Finney sold 76 shares of the business’s stock in a transaction that occurred on Monday, November 11th. The stock was sold at an average price of $1,311.75, for a total value of $99,693.00. Following the sale, the director now directly owns 240 shares in the company, valued at $314,820. This trade represents a 24.05 % decrease in their position. The disclosure for this sale can be found here. 1.94% of the stock is owned by company insiders.

Hedge Funds Weigh In On Mettler-Toledo International

Several institutional investors have recently made changes to their positions in the stock. Family Firm Inc. purchased a new stake in shares of Mettler-Toledo International during the second quarter worth $25,000. Blue Trust Inc. raised its stake in shares of Mettler-Toledo International by 242.9% during the 3rd quarter. Blue Trust Inc. now owns 24 shares of the medical instruments supplier’s stock worth $34,000 after purchasing an additional 17 shares in the last quarter. Ashton Thomas Securities LLC acquired a new stake in shares of Mettler-Toledo International during the 3rd quarter valued at about $37,000. Rothschild Investment LLC bought a new stake in shares of Mettler-Toledo International in the 2nd quarter valued at approximately $42,000. Finally, Itau Unibanco Holding S.A. bought a new position in Mettler-Toledo International during the second quarter valued at approximately $42,000. 95.07% of the stock is owned by institutional investors.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.